Navigation Links
GE Healthcare studies report results of [18F]Flutemetamol research
Date:7/20/2011

AD pathology.
  • 6-CN-Flutemetamol is comparable to 6-CN-Pittsburgh Compound-B (PiB) in its ability to bind to beta amyloid in vitro.

    "At GE Healthcare, we are fully committed to developing products and tools that enable physicians to make confident medical decisions, allowing patients to get accurate diagnosis earlier in the process," said Pascale Witz, CEO, GE Healthcare Medical Diagnostics.

    [18F]Flutemetamol is one part of a broad portfolio of diagnostic solutions that GE Healthcare is currently developing in the Alzheimer's field. The company is taking a comprehensive approach to understanding AD through its ongoing research to uncover the causes, risks and physical effects of the disease. GE Healthcare's global commitment to advance clinical knowledge and provide a variety of technologies to aid the fight in this epidemic may assist physicians in the acceleration of diagnosis and improvement of treatment decisions in all stages of the disease. The company already offers a range of imaging modalities used by physicians to assist in the detection of AD and dementia (CT, MRI, PET, SPECT) and has been a key contributor to the Alzheimer's Disease Neuroimaging Initiative since its inception. GE Healthcare also plays a key role in PredictAD, an EU-funded research project to develop solutions to enable earlier diagnosis of AD.


    '/>"/>


  • Contact: Aleisia Gibson
    Aleisia.gibson@ge.com
    609-865-4004
    Edelman Public Relations
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
    2. Phoenix conference highlights TGens and Scottsdale Healthcares contributions to molecular oncology
    3. TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
    4. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
    5. GE Healthcare President & CEO, Mark Vachon, to Present at BioConference Live
    6. GE Healthcare to evaluate and develop novel imaging technology
    7. Scott & White Healthcare researcher finds success with new anti-cancer drug
    8. Scott & White Healthcare researcher finds success with new anti-cancer drug
    9. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
    10. Inventor honored for tech improving access to clean water, healthcare, and business development in India
    11. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/14/2014)... – Like discriminating thieves, prostate cancer tumors scavenge and ... body. But such avarice may be a fatal weakness. ... way to kill prostate cancer cells by delivering a ... destroys the diseased cells brimming with the mineral, leaving ... two drugs already commercially available for other uses, could ...
    (Date:10/14/2014)... millions of years since T. rex took ... University scientists is breathing life back into dinosaurs using ... The research has important implications for how dinosaurs used ... the sense of smell and cool their brains. ... doctoral student Jason Bourke, lead author of the new ...
    (Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
    Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
    ... 22, 2010) The National Science Foundation has awarded ... Biological Laboratory $1.7 million to repair and rebuild its ... the pier has played an instrumental role in the ... change, fisheries management and the health of the Chesapeake ...
    ... reporting the development and successful initial testing of a new ... to be given as nose drops rather than injected. It ... they say. The report appears in ACS, Molecular Pharmaceutics ... note that brain cancer is difficult to treat, partly because ...
    ... water," which resembles powdered sugar, could provide a new ... greenhouse gas that contributes to global warming, scientists reported ... Society. The powder shows bright promise for a number ... be a greener, more energy-efficient way of jump-starting the ...
    Cached Biology News:UMCES Chesapeake Biological Laboratory to rebuild historic research pier 2
    (Date:10/20/2014)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced four ... million and provides a good start to Q4.  The orders are ... and one in the Middle East . ... said Peter Bruijns , President & CEO. "Total bidding activity ... they have been for any complete year since the company has ...
    (Date:10/20/2014)... GAITHERSBURG, Md. , Oct. 20, 2014  GenVec, Inc. ... Zola P. Horovitz , Ph.D., from its board of ... GenVec board in August 2003, and served as its chairman ... also served on the Nominating and Corporate Governance and Audit ... Zola for more than a decade of dedicated service to ...
    (Date:10/20/2014)... OncLive® is pleased to ... Thomas Jefferson University has joined its Strategic Alliance ... Partnership program, the Sidney Kimmel Cancer Center at ... of the Center’s cutting-edge research programs, comprehensive approach ... other health care professionals from the Sidney Kimmel ...
    (Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is seeking ... stem cells for dogs with osteoarthritis. Dr. McCarthy has ... clinical stem cell therapy for 7 years. The ultimate ... single injection of donor stem cells into one or ... inflammation in the treated joints. , Candidates for ...
    Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
    ... Sept. 23, 2011 Citizens Bank today announced that ... a major expansion by The Wistar Institute that includes ... historic facility at 36th and Spruce streets in University ... an international leader in basic biomedical research, particularly cancer ...
    ... working in collaboration with researchers from Grenoble and Tokyo, have ... more powerful computers. They were able to define two little ... to select a single electron from one of them using ... neighbouring QD. A single electron "surfs" thus from one quantum ...
    ... have for the first time provided details of ... layers of epitaxial graphene on silicon carbide wafers. ... of gas-phase silicon in the high-temperature furnace used ... for growing thin layers of graphene on silicon ...
    Cached Biology Technology:Citizens Bank Provides $70 Million in Financing Toward $100 Million Expansion of The Wistar Institute 2Like fish on waves: electrons go surfing 2Like fish on waves: electrons go surfing 3Controlling silicon evaporation allows scientists to boost graphene quality 2Controlling silicon evaporation allows scientists to boost graphene quality 3
    Polyclonal Antibody to CLAN...
    Request Info...
    IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Rabbit polyclonal to TetR ( Abpromise for all tested applications). Antigen: Synthetic peptide: AQKLGVEQPTLYWHVKNKR, corresponding to amino acids 31 - 49 of TetR...
    Biology Products: